Skip to main content

Table 2 Baseline characteristics of 272 COPD subjects according to the three subgroups

From: A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups

 

Total

1(n = 158)

2(n = 48)

3(n = 66)

p-value†

Demographics

 Gender, Male

217(79.8)

129(81.7)

43(89.6)

45(68.2)

0.0129

 Age

72.8 ± 7.3

70.2 ± 6.9

76.6 ± 4.8

75.5 ± 6.7

<.0001

 Smoking

    

0.0005

  Current

72(26.5)

50(31.6)

13(27.1)

9(13.6)

 

  Former

128(47.0)

69(43.7)

30(62.5)

29(43.9)

 

  Never

72(26.5)

39(24.7)

5(10.4)

28(42.4)

 

  Pack-year

17.8 ± 22.8

18.5 ± 23.3

22.9 ± 22.2

12.7 ± 19.0

0.0468

 BMI

23.1 ± 3.2

23.0 ± 2.7

21.9 ± 3.3

24.6 ± 3.3

<.0001

 Height

160.1 ± 8.6

160.9 ± 8.5

160. 7 ± 7.8

157.7 ± 9.1

0.0311

 Biomass exposure

95(35.5)

62(40.0)

16(34.0)

17(25.8)

0.1254

Physiology

 Stage

    

<.0001

  Mild

147(54.4)

88(55.7)

8(16.7)

52(78.8)

 

  Moderate

108(39.7)

65(41.1)

29(60.4)

14(21.2)

 

  Severe

16(5.9)

5(3.2)

11(22.9)

0(0.0)

 

 Pre FEV1, L

1.72 ± 0.57

1.87 ± 0.54

1.34 ± 0.48

1.82 ± 0.53

<.0001

 Pre FEV1, %

75.7 ± 20.7

77.8 ± 18.5

60.9 ± 16.5

88.4 ± 18.2

<.0001

 Pre FEV1/FVC

59.8 ± 9.0

61.5 ± 8.2

53.9 ± 9.4

61.4 ± 8.2

<.0001

 Post FEV1, L

1.82 ± 0.56

1.98 ± 0.51

1.45 ± 0.48

1.89 ± 0.53

<.0001

 Post FEV1, %

79.8 ± 19.7

82.3 ± 16.7

65.9 ± 17.5

91.4 ± 17.3

<.0001

 PostFEV1/FVC

58.8 ± 8.4

60.3 ± 7.4

52.8 ± 9.6

61.2 ± 6.1

<.0001

 FEV1, reversibility%

52(19.1)

29(18.4)

10(20.8)

13(19.7)

0.9207

  Emphysema index(%)

7.7 ± 7.3

6.6 ± 5.3

15.7 ± 10.0

4.1 ± 4.1

<.0001

  Mean wall area of Airway(%)

69.4 ± 5.0

69.0 ± 5.3

69.1 ± 4.4

70.0 ± 4.7

0.3535

Symptoms

 mMRC

1.49 ± 1.15

0.85 ± 0.80

2.48 ± 1.01

2.18 ± 1.02

<.0001

 0/1/2/3/4

55/112/46/43/16

52/87/13/3/3

2/6/13/21/6

1/19/20/19/7

<.0001

 CAT total

17.3 ± 9.6

12.5 ± 7.9

26.3 ± 7.5

21.5 ± 8.4

<.0001

Comorbidities

 Diabetes mellitus

42(15.7)

27(17.4)

8(17.4)

7(10.6)

0.1147

 MI

11(4.3)

5(3.3)

1(2.3)

5(7.8)

0.0885

 Heart failure

3(1.1)

1(0.7)

1(2.1)

1(1.5)

0.6696

 Cerebrovascular

4(1.5)

0(0.0)

2(4.3)

2(3.0)

0.5035

 Peptic ulcer

23(8.6)

14(9.0)

4(8.5)

5(7.6)

0.5848

Systemic inflammation index

 IL-6

2.6 ± 3.7

2.0 ± 3.2

4.7 ± 5.1

2.4 ± 2.7

<.0001

 IL-8

16.8 ± 17.8

15.4 ± 16.7

20.5 ± 24.7

17.4 ± 14.5

0.2154

 CRP

0.3 ± 0.6

0.1 ± 0.2

0.7 ± 1.2

0.2 ± 0.3

<.0001

  1. mMRC modified Medical Research Council Dyspnea Scale, MI Myocardial infarction
  2. † p values correspond to comparisons between the 3 subgroups using Chi-square test or ANOVA, as appropriate